Search alternatives:
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
significant barrier » significant burden (Expand Search)
barrier decrease » larger decrease (Expand Search), barrier disease (Expand Search), marked decrease (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), level disease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
-
21
CKO mice display decreased skin barrier function and perturbed homeostasis.
Published 2025Subjects: -
22
-
23
-
24
-
25
-
26
Metabolites with decreasing levels during the development.
Published 2025“…<p>Temporal profiles of polar metabolites and lipids with SCN levels significantly decreasing from E19 to P28. Rhythmicity was determined by eJTK; full or dashed lines depict the profiles that either did or did not pass the significance threshold (FDR-adjusted <i>P</i> < 0.05), respectively.…”
-
27
-
28
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
29
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
30
Crossing Barriers<i>: In Vitro</i> Cancer Model for Studying Monocyte Migration across Endothelial Barriers
Published 2025“…Inflammatory cytokines, such as granulocyte–macrophage colony-stimulating factor (GM-CSF), interleukin-6 (IL-6), interleukin-10 (IL-10), and interleukin-1β (IL-1β) secretion levels increased, while tumor necrosis factor α (TNF-α) and interleukin-12p40 (IL-12p40) levels decreased and monocyte chemoattractant protein-1 (MCP-1) and interleukin-8 (IL-8) levels remained unchanged in the presence of the EC barrier and spheroids, confirming the importance of the EC barrier for monocyte activation and migration. …”
-
31
-
32
Effects of busulfan treatment (6 mg/kg) on the body and testes weights of mice over three weeks.
Published 2025Subjects: -
33
-
34
-
35
Effect of busulfan treatment on vimentin, a supporting cytoskeletal protein.
Published 2025Subjects: -
36
-
37
-
38
PGAM5 knockdown prevented rTsSPc from disrupting Caco-2 monolayer integrity.
Published 2025Subjects: -
39
-
40